LAS-R BETA LIPOPROTEIN TEST— 510(k) K771912

Name: FDA 510(k) clearance K771912
Creator: U.S. Food and Drug Administration
Published: 1977-10-19

Substantially Equivalent

Hyland Therapeutic Div., Travenol Laboratories

FDA 510(k) clearance K771912 for LAS-R BETA LIPOPROTEIN TEST, Substantially Equivalent on 1977-10-19. Applicant: Hyland Therapeutic Div., Travenol Laboratories. Device class: 2.

Clearance details

Applicant: Hyland Therapeutic Div., Travenol Laboratories
Product code: Code DFC
Device class: Class 2
Regulation: 21 CFR 866.5600
Advisory panel: Immunology
Date received: 1977-10-11
Decision date: 1977-10-19
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Mchenry, IL, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code DFC

view all

K253069 — Lipoprotein (a) Molarity Assay2026-06-16
K241220 — Tina-quant Lipoprotein(a) Gen.2 Molarity2025-01-24
K211058 — Lp(a) Ultra2022-12-22
K180074 — Diazyme Lipoprotein (a) Assay2018-03-22
K123046 — ADVIA CHEMISTRY LIPOPROTEIN(A) REAGENT ADVIA CHEMISTRY LIPOPROTEIN(A) CALIBRATOR2012-12-20

More clearances from Hyland Therapeutic Div., Travenol Laboratories

view all

K820835 — ALUMINA SILICA-ACTIVATED PARTIAL THROM1982-04-26
K820192 — HAEMOPHILUS INFLUENZAE TYPE B ANTISERUM1982-03-11
K812220 — NEPHELOMETRIC SOLID TURBIDITY STANDARD1981-08-18
K810078 — Q-PAK THERAPEUTIC DRUG MONIT. CONTROL S1981-02-02
K810077 — OMEGA THERAPEUTIC DRUG MONIT. CONTROL S.1981-01-28

Data sourced from openFDA. This site is unofficial and independent of the FDA.